Love Hemp Group Plc (WRHLF)

0.0000 0.0000 (0.00%) As of 11:40AM EDT. Market open.

Love Hemp Group Plc

7-9 Swallow Street
2nd Floor
London W1B 4DE
United Kingdom
44 2039 785 322
https://www.worldhighlife.uk

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 28

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Antonio Luigi Calamita	Founder, CEO & MD	N/A	N/A	1985
Mr. Anthony Dyer	Director & Interim CFO	N/A	N/A	N/A
James Martin	Chief Operating Officer	N/A	N/A	N/A
Ms. Anna Rebecca Legge	Chief Communications Officer	N/A	N/A	N/A
Mr. Stephen White	Chief Marketing Officer	N/A	N/A	N/A
Mr. Steve Horan	Head of Marketing	N/A	N/A	N/A
Mr. Martin Healy	Chief Growth Officer	N/A	N/A	N/A
Adam Pritchard	Chief Commercial Officer	N/A	N/A	N/A
Mr. Ian Munzberger	Chief Brand & Partnerships Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Love Hemp Group Plc is a private equity and venture capital firm specializing in acquisition, early stage and mature companies. It may invest as debt or equity, in either quoted or unquoted securities, and made by direct acquisition of an interest in companies, partnerships or joint ventures, or direct interests in projects, or by way of licensing arrangements. It typically invests in companies operating in the Cannabidiol (CBD) wellness and medicinal cannabis, hemp including the industrial hemp with focus on therapeutic cannabis derivatives including nutraceuticals, dietary supplements and cosmetic products. The firm also seeks to invest in the cultivation of cannabis and hemp, premium quality, feel good CBD oils, edibles, cosmetics, capsules, the manufacture and distribution of medicinal cannabis, hemp and CBD products, pharmacology commercialization of medicinal cannabis, hemp and CBD, professional prescription by practitioners and after care as it relates to medicinal cannabis, statistical management, laboratory testing and compliance in respect of medicinal cannabis, hemp and CBD sectors, and the development of CBD within the wellness sector including retail products such as patches, topical ointments, tinctures, beverages, powdered supplements as well as vaping capsules, e-liquids and oils. The firm typically invests in Europe, United Kingdom, Germany, Netherlands, North America, Australia, Japan, Thailand, Canada, Africa and South America, Israel and Asia. The firm will hold investments for the medium to long term, although where opportunities exist for shorter-term investments, it may undertake such investments. The firm typically acquire control in certain situations, although it may also consider acquiring non-controlling positions. The firm seeks to take majority stake. Love Hemp Group Plc was founded on 30th January 2019 and is based in London, United Kingdom with additional offices in London, United Kingdom.

Corporate governance

Love Hemp Group Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.